View in EDS

Integrating a Polygenic Risk Score into a clinical setting would impact risk predictions in familial breast cancer.

Saved in:

Bibliographic Details
Title:	Integrating a Polygenic Risk Score into a clinical setting would impact risk predictions in familial breast cancer.
Authors:	Baliakas P; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Munters AR; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Kämpe A; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden., Tesi B; Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.; Department of Clinical Genetics, Karolinska Institutet, Stockholm, Sweden., Bondeson ML; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Ladenvall C; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Eriksson D; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden daniel.eriksson@igp.uu.se.; Department of Clinical Genetics, Akademiska Sjukhuset, Uppsala, Sweden.
Source:	Journal of medical genetics [J Med Genet] 2024 Jan 19; Vol. 61 (2), pp. 150-154. Date of Electronic Publication: 2024 Jan 19.
Publication Type:	Journal Article; Research Support, Non-U.S. Gov't
Journal Info:	Publisher: British Medical Association Country of Publication: England NLM ID: 2985087R Publication Model: Electronic Cited Medium: Internet ISSN: 1468-6244 (Electronic) Linking ISSN: 00222593 NLM ISO Abbreviation: J Med Genet Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1468-6244
DOI:	10.1136/jmg-2023-109311